Betty Sizemore
Family · Manchester, KYNPI 1215333133
Payments from drug & device makers
Across 205 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$802
- Novo Nordisk$565
- GSK$429
- Merck$158
- Lilly USA, LLC$129
- plus $713 from 14 others
What the payments were for
- Food & beverage$3,827100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $1,048 |
| AbbVie | 51 | $802 |
| Novo Nordisk | 32 | $565 |
| GSK | 31 | $429 |
| Merck | 9 | $158 |
| Lilly USA, LLC | 8 | $129 |
| Medtronic | 5 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $91 |
| Dexcom, Inc. | 5 | $85 |
| Insulet Corporation | 3 | $65 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Bayer | 3 | $59 |
| Astellas Pharma US Inc | 4 | $58 |
| Johnson & Johnson | 2 | $45 |
| Pfizer | 3 | $45 |
| Ardelyx, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Verona Pharma, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,844 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 217 | $219,011 |
| JardianceEmpagliflozin | 111 | $77,047 |
| LinzessLinaclotide | 129 | $71,650 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 106 | $66,185 |
| EliquisApixaban | 98 | $60,468 |
| MounjaroTirzepatide | 51 | $52,926 |
| FarxigaDapagliflozin Propanediol | 92 | $48,617 |
| Ondansetron Hcl | 269 | $48,096 |
| JanuviaSitagliptin Phosphate | 79 | $43,910 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $36,648 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $27,429 |
| VraylarCariprazine Hcl | 16 | $22,746 |
| VascepaIcosapent Ethyl | 54 | $22,741 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 35 | $22,379 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $18,970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Levemir | $565 | $224,414234 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Brilinta | $1,048 | $122,872217 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $13 | $98,866155 claims |
| AbbVieLinzess, Vraylar | $802 | $94,396145 claims |
| Lilly USA, LLCMounjaro, Trulicity | $129 | $70,26069 claims |
| PfizerEliquis, Premarin | $45 | $70,242127 claims |
| MerckJanuvia, Janumet Xr | $158 | $51,22992 claims |
| GSKTrelegy Ellipta | $429 | $27,42943 claims |
| Johnson & JohnsonXarelto | $45 | $13,89325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Manchester
- Eva EdwardsManchester$14K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.